Last reviewed · How we verify

Malathion gel 0.5%

Sun Pharmaceutical Industries, Inc. · Phase 3 active Small molecule

Malathion is an organophosphate insecticide that inhibits acetylcholinesterase, causing accumulation of acetylcholine and paralysis of parasites.

Malathion is an organophosphate insecticide that inhibits acetylcholinesterase, causing accumulation of acetylcholine and paralysis of parasites. Used for Head lice infestation (pediculosis capitis), Scabies (Sarcoptes scabiei infestation).

At a glance

Generic nameMalathion gel 0.5%
Also known asMALG
SponsorSun Pharmaceutical Industries, Inc.
Drug classOrganophosphate insecticide
TargetAcetylcholinesterase
ModalitySmall molecule
Therapeutic areaDermatology / Parasitology
PhasePhase 3

Mechanism of action

Malathion works by irreversibly inhibiting the enzyme acetylcholinesterase in insects and parasites, leading to excessive acetylcholine accumulation at nerve synapses and neuromuscular junctions. This results in overstimulation, paralysis, and death of the target organisms. The gel formulation allows topical application for localized treatment of parasitic infestations.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: